Skip to content

Hove Pharma: what changed

BE 0737.798.331NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€51,083
2024 · €32,317+€18,766
Equity
€227,556
2024 · €190,473+€37,083
Cash
€25,326
2024 · €12,735+€12,591
Balance sheet total
€849,286
2024 · €806,526+€42,759

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€33,402

    up €33,402 (+34.5%), from €96,769 to €130,171

    of which Trade receivables: +€23,336

  • Intangible fixed assets -€28,500

    down €28,500 (-20.0%), from €142,500 to €114,000

  • Stocks and contracts +€16,914

    up €16,914 (+12.1%), from €139,579 to €156,493

  • Cash +€12,591

    up €12,591 (+98.9%), from €12,735 to €25,326

    mainly Depreciation (+€62,628) and Net result for the year (+€51,083)

Equity and liabilities
  • Debts after one year -€57,108

    down €57,108 (-12.7%), from €450,439 to €393,332

  • Trade debts +€46,196

    up €46,196 (+47.1%), from €98,151 to €144,347

  • Reserves +€37,083

    up €37,083 (+33.6%), from €110,473 to €147,556

  • Other debts +€13,150

    up €13,150 (+329%), from €4,000 to €17,150

Income statement
  • Gross operating margin +€55,348

    up €55,348 (+38.6%), from €143,467 to €198,814

  • Staff costs +€27,847

    up €27,847 (+95.6%), from €29,143 to €56,990

  • Taxes +€11,495

    up €11,495 (+682%), from €1,685 to €13,179

  • Financial charges -€4,543

    down €4,543 (-23.2%), from €19,548 to €15,005

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €32,317
Gross operating margin +€55,348
Staff costs -€27,847
Depreciation -€1,909
Other operating charges +€262
Financial income -€136
Financial charges +€4,543
Taxes -€11,495
Result 2025 €51,083
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€125,175
Investment -€42,076
Financing -€70,508
Cash 2024 €12,735
Net result for the year +€51,083
Depreciation +€62,628
Stocks and contracts -€16,914
Receivables within one year -€33,402
Deferred charges and accrued income -€405
Trade debts +€46,196
Tax, wage and social debts +€3,654
Other debts +€13,150
Accrued charges and deferred income -€816
Investment in fixed assets (net) -€42,076
Debts after one year -€57,108
Current portion of long-term debt +€600
Contributions, distributions and other -€14,000
Cash 2025 €25,326
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €806,526 €849,286 +€42,759 +5.3%
Fixed assets 21/28 €555,450 €534,898 -€20,552 -3.7%
Intangible fixed assets 21 €142,500 €114,000 -€28,500 -20.0%
Tangible fixed assets 22/27 €412,950 €420,898 +€7,948 +1.9%
Land and buildings 22 €343,376 €323,776 -€19,600 -5.7%
Plant, machinery and equipment 23 €69,574 €57,218 -€12,356 -17.8%
Other tangible fixed assets 26 - €39,904 +€39,904
Current assets 29/58 €251,076 €314,388 +€63,312 +25.2%
Stocks and contracts in progress 3 €139,579 €156,493 +€16,914 +12.1%
Stocks 30/36 €139,579 €156,493 +€16,914 +12.1%
Amounts receivable within one year 40/41 €96,769 €130,171 +€33,402 +34.5%
Trade receivables 40 €71,669 €95,005 +€23,336 +32.6%
Other amounts receivable 41 €25,100 €35,165 +€10,066 +40.1%
Cash at bank and in hand 54/58 €12,735 €25,326 +€12,591 +98.9%
Deferred charges and accrued income 490/1 €1,993 €2,398 +€405 +20.3%
Total equity and liabilities 10/49 €806,526 €849,286 +€42,759 +5.3%
Equity 10/15 €190,473 €227,556 +€37,083 +19.5%
Contributions 10/11 €80,000 €80,000 = 0.0%
Reserves 13 €110,473 €147,556 +€37,083 +33.6%
Distributable reserves 133 €110,473 €147,556 +€37,083 +33.6%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €616,053 €621,730 +€5,676 +0.9%
Amounts payable after more than one year 17 €450,439 €393,332 -€57,108 -12.7%
Financial debts 170/4 €450,439 €393,332 -€57,108 -12.7%
Amounts payable within one year 42/48 €162,735 €226,334 +€63,600 +39.1%
Current portion of amounts payable after more than one year 42 €56,508 €57,108 +€600 +1.1%
Trade debts 44 €98,151 €144,347 +€46,196 +47.1%
Suppliers 440/4 €98,151 €144,347 +€46,196 +47.1%
Taxes, remuneration and social security 45 €4,075 €7,730 +€3,654 +89.7%
Taxes 450/3 €0 €197 +€197
Remuneration and social security 454/9 €4,075 €7,533 +€3,458 +84.8%
Other amounts payable 47/48 €4,000 €17,150 +€13,150 +329%
Accrued charges and deferred income 492/3 €2,879 €2,064 -€816 -28.3%
Remuneration, social security and pensions 62 €29,143 €56,990 +€27,847 +95.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €60,719 €62,628 +€1,909 +3.1%
Other operating charges 640/8 €600 €338 -€262 -43.7%
Gross operating margin 9900 €143,467 €198,814 +€55,348 +38.6%
Operating profit (loss) 9901 €53,005 €78,858 +€25,854 +48.8%
Financial income 75/76B €544 €409 -€136 -24.9%
Recurring financial income 75 €544 €409 -€136 -24.9%
Financial charges 65/66B €19,548 €15,005 -€4,543 -23.2%
Recurring financial charges 65 €19,548 €15,005 -€4,543 -23.2%
Profit (loss) for the period before taxes 9903 €34,001 €64,262 +€30,261 +89.0%
Income taxes 67/77 €1,685 €13,179 +€11,495 +682%
Profit (loss) for the period 9904 €32,317 €51,083 +€18,766 +58.1%
Profit (loss) for the period to be appropriated 9905 €32,317 €51,083 +€18,766 +58.1%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€182,903 to €233,353

Midpoint €203,924 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €113,556
Capitalised earnings €252,250 to €353,150
Indication €182,903 to €233,353

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€227,556
Intangible fixed assets (21)
-€114,000
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€113,556

Capitalised earnings

net result for the year (9904)
2025
€51,083
2024
€32,317
2023
€22,547
2022
-€59,044
excluding non-recurring income and charges
-€57,628
2021
€73,218
Average result
€35,315
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€252,250 / €294,292 / €353,150

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.